Literature DB >> 3157704

Uptake of ciprofloxacin by macrophages.

C S Easmon, J P Crane.   

Abstract

Ciprofloxacin was concentrated within mouse peritoneal macrophages to between two and three times extracellular values. Uptake was rapid, occurred equally well with dead cells, and was not affected by lowering the pH or by prior ingestion of Staphylococcus aureus. Intracellular staphylococci were killed by extracellular concentrations of ciprofloxacin as low as 0.5 mg/l.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157704      PMCID: PMC499174          DOI: 10.1136/jcp.38.4.442

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

2.  Activities of newer quinolones against Legionella group organisms.

Authors:  D Greenwood; A Laverick
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

3.  Effects of phagocytosis on antibiotic and nucleoside uptake by human polymorphonuclear leukocytes.

Authors:  T H Steinberg; W L Hand
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

4.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

5.  Cellular uptake of clindamycin and lincomycin.

Authors:  C S Easmon; J P Crane
Journal:  Br J Exp Pathol       Date:  1984-12
  5 in total
  34 in total

1.  Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.

Authors:  M Hussein Gasem; Monique Keuter; Wil M V Dolmans; Johanna Van Der Ven-Jongekrijg; Robert Djokomoeljanto; Jos W M Van Der Meer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Lack of effective bactericidal activity of new quinolones against Brucella spp.

Authors:  J A García-Rodriguez; J E García Sánchez; I Trujillano
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

3.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  Fluoroquinolone transport by human monocytes: characterization and comparison to other cells of myeloid lineage.

Authors:  S J Bounds; R Nakkula; J D Walters
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Mechanisms of fluoroquinolone transport by human neutrophils.

Authors:  J D Walters; F Zhang; R J Nakkula
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes.

Authors:  A Pascual; I Garcia; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

7.  Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.

Authors:  H Brunner; H J Zeiler
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

8.  Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin.

Authors:  T Butler; M R Jacobs; D Farhi
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 9.  Quinolones in Salmonella typhi infection.

Authors:  H L DuPont
Journal:  Drugs       Date:  1993       Impact factor: 9.546

10.  Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy.

Authors:  M L Patchen; I Brook; T B Elliott; W E Jackson
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.